3-[3-[(1S)-1-(methylamino)-2,3-dihydro-1H-inden-5-yl]-5-pyrazol-1-ylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
C24H22N8 — CID 177272462
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[3-[(1S)-1-(methylamino)-2,3-dihydro-1H-inden-5-yl]-5-pyrazol-1-ylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
3-[3-[(1S)-1-(methylamino)-2,3-dihydro-1H-inden-5-yl]-5-pyrazol-1-ylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine (PubChem CID 177272462) has the molecular formula C24H22N8 and a molecular weight of 422.50 g/mol. Its IUPAC name is 3-[3-[(1S)-1-(methylamino)-2,3-dihydro-1H-inden-5-yl]-5-pyrazol-1-ylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine.
Molecular Properties
| Compound Name | 3-[3-[(1S)-1-(methylamino)-2,3-dihydro-1H-inden-5-yl]-5-pyrazol-1-ylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine |
|---|---|
| PubChem CID | 177272462 |
| Molecular Formula | C24H22N8 |
| Molecular Weight | 422.50 g/mol |
| Exact Mass | 422.20 |
| IUPAC Name | 3-[3-[(1S)-1-(methylamino)-2,3-dihydro-1H-inden-5-yl]-5-pyrazol-1-ylimidazo[4,5-b]pyridin-2-yl]pyridin-2-amine |
| SMILES | CN[C@H]1CCc2cc(-n3c(-c4cccnc4N)nc4ccc(-n5cccn5)nc43)ccc21 |
| InChI | InChI=1S/C24H22N8/c1-26-19-8-5-15-14-16(6-7-17(15)19)32-23(18-4-2-11-27-22(18)25)29-20-9-10-21(30-24(20)32)31-13-3-12-28-31/h2-4,6-7,9-14,19,26H,5,8H2,1H3,(H2,25,27)/t19-/m0/s1 |
| InChIKey | MYHVXCHCSGPHDO-IBGZPJMESA-N |
| XLogP | 3.46 |
| TPSA | 99.47 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 422.50 |
| LogP ≤ 5 | 3.46 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 177272462 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.